Squarepoint’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Buy |
+35,088
| New | +$456K | ﹤0.01% | 1956 |
|
|
2025
Q1 | – | Sell |
-10,102
| Closed | -$171K | – | 2747 |
|
|
2024
Q4 | $171K | Sell |
10,102
-22,752
| -69% | -$386K | ﹤0.01% | 2424 |
|
|
2024
Q3 | $763K | Buy |
32,854
+3,355
| +11% | +$77.9K | ﹤0.01% | 1560 |
|
|
2024
Q2 | $718K | Buy |
+29,499
| New | +$718K | ﹤0.01% | 1538 |
|
|
2024
Q1 | – | Sell |
-8,795
| Closed | -$277K | – | 2417 |
|
|
2023
Q4 | $277K | Sell |
8,795
-5,252
| -37% | -$166K | ﹤0.01% | 1993 |
|
|
2023
Q3 | $359K | Buy |
+14,047
| New | +$359K | ﹤0.01% | 1820 |
|
|
2021
Q2 | – | Sell |
-8,609
| Closed | -$356K | – | 2596 |
|
|
2021
Q1 | $356K | Buy |
+8,609
| New | +$356K | ﹤0.01% | 1766 |
|
|
2020
Q3 | – | Sell |
-4,796
| Closed | -$224K | – | 2314 |
|
|
2020
Q2 | $224K | Buy |
+4,796
| New | +$224K | ﹤0.01% | 1707 |
|
|
2020
Q1 | – | Sell |
-54,600
| Closed | -$594K | – | 1833 |
|
|
2019
Q4 | $594K | Buy |
54,600
+16,600
| +44% | +$181K | ﹤0.01% | 1625 |
|
|
2019
Q3 | $390K | Buy |
+38,000
| New | +$390K | ﹤0.01% | 1682 |
|
|
2017
Q1 | – | Sell |
-5,657
| Closed | -$83K | – | 1503 |
|
|
2016
Q4 | $83K | Buy |
+5,657
| New | +$83K | ﹤0.01% | 1648 |
|